Delivery Order SPE2DB22D1017-SPE2DB24FG4UD

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,308.56 firm fixed-price delivery order is for the supply of 4565781848 - Candesartan Cilexetil 16 mg Tablets in 90-count bottles. The award is not associated with a set-aside program and has an ultimate completion date of September 13, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $33,385.99 fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,566,514,819 units of Candesartan Cilexetil 32 mg tablets. The firm-fixed-price delivery order, valued at $2,264.64, has a completion date of November 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is a delivery order with a firm fixed price of $9,890.36 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,565,404,314 units of Candesartan Cilexetil 16 MG tablets, which are likely a critical pharmaceutical product used by the U.S. military and other federal healthcare programs. The contract has an ultimate completion date of August 12, 2024. Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,347.24 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,127.39 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 4 mg tablets in 90-count packages. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,875.50, is for the delivery of Candesartan Cilexetil 16 mg tablets. It is a firm fixed price delivery order contract that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,357.54 Firm Fixed Price Delivery Order contract is for the supply of 4,567,599,451 units of Candesartan Cilexetil 8 mg tablets. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,840.66 Firm Fixed Price delivery order contract is for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of July 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,032.02 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The award has an ultimate completion date of August 23, 2024 and does not utilize any set-aside. Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG4UD
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $6,933.79 and a completion date of September 11, 2024. The award is for the supply of Candesartan Cilexetil 16 mg tablets in 90-count packages. This contract is not set aside for any specific business type. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical supplies to support government healthcare programs and facilities. These IDCs serve as primary vehicles for Amerisourcebergen to efficiently deliver essential medical commodities to federal agencies.

Generated 12/10/24, 2:33 PM